←
BIOVECTRA708 posts
BIOVECTRA avatar

BIOVECTRA

@BioVectra

A global, full-service CDMO specializing in biologics, small molecules, pDNA/mRNA manufacturing, HPAPIs, & bioreagents.

◷ Joined February 2015▧ 258 Photos and videos
BIOVECTRA avatar
BIOVECTRA@BioVectra·11 Apr 2024

Contract Pharma recently interviewed Marc Sauer about what BIOVECTRA has been up to the past several months, including our new biomanufacturing facility in Charlottetown, PE, and our partnership with Acuitas Therapeutics. Read the full interview here: contractpharma.com/issues/20…

Post attachment
BIOVECTRA avatar
BIOVECTRA@BioVectra·13 Dec 2023

Read our newest article, authored by Jean-François Vincent-Rocan & published in Pharma's Almanac, to learn more about synthetic chemistry has key role in enabling us to offer reliable, efficient, & cost-effective solutions to our clients today. pharmasalmanac.com/articles/…

Post attachment
BIOVECTRA avatar
BIOVECTRA@BioVectra·8 Dec 2023

Since the pandemic, there has been renewed interest in exploring time-to-market for various therapeutics. In this new article featuring BIOVECTRA’s Peter Ercoli, experts explore how the process can be accelerated without compromising quality. ow.ly/M0Rh50QgEYO

Post attachment
BIOVECTRA avatar
BIOVECTRA@BioVectra·30 Nov 2023

In this webinar, we'll dive into ADC manufacturing and the recommended strategies to overcome common potency testing and product purity challenges, as well as share insights into the advantages of utilizing cGMP grade DHAA and TCEP in ADC manufacturing ow.ly/inI750Qe8L8

Post attachment
BIOVECTRA avatar
BIOVECTRA@BioVectra·23 Nov 2023

Discover how BIOVECTRA can best support your upcoming biologics and complex chemistry projects at next week's BOS Manchester. With 50+ years of pharmaceutical manufacturing experience, we can deliver you solutions quickly and efficiently. ow.ly/GIuo50QaGXY

Post attachment
BIOVECTRA avatar
BIOVECTRA@BioVectra·9 Nov 2023

[Webinar Alert] Join Jessica Madigan to gain insights into commercial manufacturing in mRNA clinical therapies, as well as the challenges and inventive solutions to be aware of for development, scaling and commercialization. ow.ly/5XXO50Q6405

Post attachment
BIOVECTRA avatar
BIOVECTRA@BioVectra·18 Oct 2023

As a manufacturer of both small molecules and biologics, BIOVECTRA is ideally positioned to support clients developing #mrna vaccines and therapeutics. Check out the latest in Pharma's Almanac to learn about our fit-for-purpose manufacturing solutions: pharmasalmanac.com/articles/…

Post attachment
BIOVECTRA avatar
BIOVECTRA@BioVectra·4 Oct 2023

At BIOVECTRA, microbial fermentation is core to much of what we do so we're thrilled - but not surprised - to see two of our own featured in BioPharm International's piece, "Optimizing Fermentation Processes for Biologics Manufacturing." Check it out! bit.ly/48HIQ1y

Post attachment
CASTL avatar
⟳ BIOVECTRA retweeted
CASTL@CastlCanada·11 Aug 2023

CASTL trainers had the pleasure of touring the progress of the new @BioVectra pDNA and mRNA manufacturing facility in preparation for our upcoming customized training. Learn more about the project: bitly.ws/REZi #pei

Post attachment